₹2291.7041.501.84%(1D)
Performance Stats for Lupin
Day Range
Low: ₹2254.80
High: ₹2299.70
52 Week Range
Low: ₹1795.20
High: ₹2263.00
Open Price
2267.20Previous Close
2250.20Volume
971701.00Open Price
2267.20Previous Close
2250.20Volume
971701.00Fundamentals of Lupin
ROCE
21.32%
EPS
₹120.99
Dividend Yield
0.59%
P/E Ratio
23.29
P/B Ratio
3.81
Debt to Equity
0.01
Current Ratio
2.55
Sales Growth
18.61%
Profit Growth
79.22%
EBIT Growth
79.05%
Financials of Lupin
All values in Rs. Cr
All values in Rs. Cr
All values in Rs. Cr
Share Holding Pattern of Lupin
About Lupin
Lupin is an innovation led Transnational Pharmaceutical Company producing, developing and marketing a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally. The Company has signific...
Read more
Similar Sector Stocks
| Stocks | CMP |
| Alembic Pharma | ₹743.45 0.99% |
| Aurobindo Pharma | ₹1214.8 4.33% |
| Cipla | ₹1344.3 1.33% |
| Glenmark Pharmaceuticals | ₹2085.5 1.31% |
Most Viewed Stocks
Open Interest (OI)
Lupin Options
| Price | OI | Volume |
Events Related to Lupin
Board Meeting
Feb 12, 2026
Board Meeting
Jan 6, 2026
Board Meeting
Nov 6, 2025
AGM
Aug 11, 2025
Board Meeting
Aug 5, 2025
News About Lupin
Stocks in news: IRFC, Voltas, IDFC First Bank, Alembic Pharma, Lupin
Feb 25, 2026
SBI, L&T among 4 stocks that hit 52-week highs & rallied up to 16% in a month
Feb 17, 2026
Stocks To Watch Today: Cochin Shipyard, Lupin, NTPC, Zydus Wellness, Arihant Foundations & Housing
Feb 17, 2026
Buy, Sell, Hold: Lupin, TCS, Infosys, Apollo Hospitals, Titagarh Rail Systems — Ask Profit
Feb 16, 2026
Lupin Delivers Beat In Q3: Nomura, Citi Raise Target Price, Morgan Stanley Turns More Optimistic
Feb 16, 2026
